paclitaxel has been researched along with Diabetic Cardiomyopathies in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, J; Hou, Z; Ouyang, H; Song, L; Tao, Z; Xie, S; Xu, J; Zeng, X; Zhang, C | 1 |
1 review(s) available for paclitaxel and Diabetic Cardiomyopathies
| Article | Year |
|---|---|
A meta-analysis of everolimus-eluting stents versus sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients.
Topics: Cardiovascular Agents; Diabetic Angiopathies; Diabetic Cardiomyopathies; Drug-Eluting Stents; Everolimus; Humans; Paclitaxel; Randomized Controlled Trials as Topic; Sirolimus; Treatment Outcome | 2021 |